ASTHMA AND COPD MARKET ANALYSIS

Asthma And COPD Market, By Drug Type (Bronchodilators (Short Acting Bronchodilators, Long Acting Bronchodilators), Anti-Inflammatories (Inhaled Corticosteroids, Leukotriene Modulators and Others), Combination Therapies), By Disease Type (Asthma, and COPD), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe Asia, Pacific Middle East & Africa) -

Published In : Jul 2023
Code : CMI4002
Pages :183
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Asthma And COPD Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global asthma and COPD market over the forecast period. This is due to the increasing number of research & development activities in the region. For instance, according to the data published by American researchers in The Journal of Medicinal Chemistry, a U.S.-based biweekly peer-reviewed medical journal covering research in medicinal chemistry, on March 13, 2023, activating the taste receptors that are located all over the body, opens up lung passageways. Hence, they are a potential target for treating asthma or chronic obstructive pulmonary disease (COPD).

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa